Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome )Clinical Mucopolysaccharidosis VI Clinical Trials Market | Page 3

Clinical Trials by E7 Countries: Proportion of Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy
Syndrome ) to Metabolic Disorders Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome )
Therapeutics Clinical Trials 25
Prominent Drugs 26
View summary of this report @ http://www.radiantinsights.com/research/mucopolysaccharidosisvi-mps-vi-maroteaux-lamy-syndrome-global-clinical-trials-review-h1-2016
Clinical Trial Profile Snapshots 27
Appendix 43
Abbreviations 43
Definitions 43
Research Methodology 44
Secondary Research 44
About Global Data 45
Contact Us 45
Disclaimer 45
Source 46

List of Tables